GLATIRAMER ACETATE
Generic: GLATIRAMER ACETATE INJECTION
UPSHER-SMITH LABORATORIESManufacturer
SUBCUTANEOUSRoute
GLATIRAMER ACETATEActive Substance
2025-12-31Original Approval
GLATIRAMER ACETATE is FDA application ANDA214741, sponsored by SCINOPHARM TAIWAN. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
INJECTION SITE PAIN
784 reports
2
MULTIPLE SCLEROSIS
657 reports
3
DRUG INEFFECTIVE
618 reports
4
MULTIPLE SCLEROSIS RELAPSE
603 reports
5
INJECTION SITE ERYTHEMA
427 reports
6
INJECTION SITE MASS
373 reports
7
FATIGUE
340 reports
8
DYSPNOEA
319 reports
9
INJECTION SITE SWELLING
318 reports
10
INJECTION SITE PRURITUS
267 reports